Objective:
To assess the progression of diabetic retinopathy (DR) in a patient with type 2 diabetes using electroretinography (ERG), highlighting the significance of ERG in monitoring retinal health.
Key Findings:
- Initial retinal findings indicated unilateral DR, which progressed to bilateral DR over time, particularly after the introduction of GLP-1 treatment.
- The patient's HbA1c improved with GLP-1 treatment, but retinal health deteriorated, suggesting a potential adverse effect of the medication.
- ERG scores indicated a significant risk of requiring intervention due to DR, highlighting the importance of monitoring.
Interpretation:
The case highlights the importance of monitoring retinal health in diabetic patients, especially those on GLP-1 agonists, as they may have adverse effects on DR progression.
Limitations:
- The patient's delayed follow-up may have contributed to the progression of DR, emphasizing the need for timely monitoring.
- The study is based on a single case, limiting generalizability and necessitating further research.
Conclusion:
Regular monitoring and early intervention are crucial in managing diabetic retinopathy, particularly in patients undergoing treatment for diabetes, as GLP-1 agonists may pose risks to retinal health.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


